Advanced search
Publication Cover
Modern Rheumatology Volume 19, 2009 - Issue 5
Journal homepage
138
Views
84
CrossRef citations to date
0
Altmetric
Original Article

Colchicine versus placebo in Behçet’s disease: randomized, double-blind, controlled crossover trial

Fereydoun DavatchiBehçet’s Disease Unit, Rheumatology Research Center, Tehran University for Medical Sciences, Shariati Hospital, Kargar Avenue, 14114 Tehran, IranCorrespondence[email protected]
,
Bahar Sadeghi AbdollahiBehçet’s Disease Unit, Rheumatology Research Center, Tehran University for Medical Sciences, Shariati Hospital, Kargar Avenue, 14114 Tehran, Iran
,
Arash Tehrani BanihashemiBehçet’s Disease Unit, Rheumatology Research Center, Tehran University for Medical Sciences, Shariati Hospital, Kargar Avenue, 14114 Tehran, Iran
,
Farhad ShahramBehçet’s Disease Unit, Rheumatology Research Center, Tehran University for Medical Sciences, Shariati Hospital, Kargar Avenue, 14114 Tehran, Iran
,
Abdolhadi NadjiBehçet’s Disease Unit, Rheumatology Research Center, Tehran University for Medical Sciences, Shariati Hospital, Kargar Avenue, 14114 Tehran, Iran
,
Hormoz ShamsBehçet’s Disease Unit, Rheumatology Research Center, Tehran University for Medical Sciences, Shariati Hospital, Kargar Avenue, 14114 Tehran, Iran
&
Cheyda Chams-DavatchiBehçet’s Disease Unit, Rheumatology Research Center, Tehran University for Medical Sciences, Shariati Hospital, Kargar Avenue, 14114 Tehran, Iran
 show all
Pages 542-549 | Received 10 Apr 2009, Accepted 10 Jun 2009, Published online: 02 Jan 2014

References

  • Mizushima Y, Matsumura N, Shimizu T, Fukushima B, Mimura Y, Saito K, et al. Colchicine in Behçet's disease. Lancet. 1977;2:1037.
  • Haim S, Friedman-Bimbaum R. Colchicine in Behçet's disease. Harefuah. 1977;93:399–400.
  • Hazen PG, Michel B. Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behçet's syndrome. Arch Dermatol. 1979;115:1303–6.
  • Raynor A, Askari AD. Behçet's disease and treatment with colchicine. J Am Acad Dermatol. 1980;2:396–400.
  • Miyachi Y, Tanigushi S, Ozaki M, Horio T. Colchicine in the treatment of the cutaneous manifestations of Behçet's disease. Br J Dermatol. 1981;104:67–9.
  • Moreno Moraga J, Estrada Saiz RV, Chantres Antoraz MT, Rivas Flores J, Gilsanz Garcia V. Therapeutic values of colchicine in Behçet's disease. Med Clin (Bart). 1981;77:18–20.
  • Harper RM, Allen BS. Use of colchicine in the treatment of Behçet's disease. Int J. Dermatol. 1982;21:551–4.
  • Sander HM, Randle HW. Use of colchicine in Behçet's syn-drome. Cutis. 1986;37:344–8.
  • Aktulga E, Altac M, Muftuoglu Y, Pazarli H, Tuzun Y, Yalcin B, et al. A double blind study of colchicine in Behçet's disease. Haematologica. 1980;65:399–402.
  • Yurdakul S, Mat C, Tuzun Y, Ozyazgan Y, Hamuryudan V, Omer Uysal, et al. A double-blind trial of colchicine in Behçet's syndrome. Arthritis Rheum. 2001;44:2686–92.
  • Fontes V, Machet L, Huttenberger B, Lorette G, Vaillant L. Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases. Ann Dermatol Venereol. 2002;129: 1365–9.
  • Vidaller Palacin A, Robert Olalla J, Sanuy Jimenez B, Rufi Rigau G, Folch Civit J, Charte Gonzales A. Behçet's disease therapy review. Ann Med Int. 2002;19:594–8.
  • Wechsler B. Colchicine and Behçet's disease: an efficacious treatment finally recognized. Rev Med Int. 2002;23:355–6.
  • Lange U, Schumann C, Schmidt KL. Current aspects of colchi-cine therapy-classical indications and new therapeutic uses. Eur J Med Res. 2001;20:150–60.
  • Davatchi F, Jamshidi AR, Tehrani-Banihashemi A, Gholami J, Forouzanfar MH, Moradi M, et al. Prevalence of Behçet's disease in Iran: a WHO-ILAR COPCORD Stage 1 study. APLAR J Rheumatol. 2007;10: 239–43.
  • Davatchi F, Akbarian M, Shahram F, Tebbi ME, Chams C, Shams H. Iran Behçet's disease dynamic activity measure. Abstracts of the XIIth European Congress of Rheumatology. Hungarian Rheumatol 1991;32(Suppl):FP10–100.
  • Jamshidi A, Shahram F, Akbarian M, Gharibdoost F, Nadji A, Chams C, et al. The accuracy of IBDDAM (Iran Behçet's disease dynamic activity measure) in the treatment evaluation of Behçet's disease. APLAR J Rheumatol. 2001;4:161–3.
  • Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ. Behçet's disease evaluation of a new instrument to measure clinical activity. Rheumatology. 1999;38:728–33.
  • Lawton G, Bhakta BB, Chamberlain MA, Tennant A. The Behçet's disease activity index. Rheumatology 2004;43:73–8.
  • Shahram F, Khabbazi A, Nadji A, Ziaie N, Tehrani Banihashemi A, Davatchi F. Comparison of the existing disease activity indices in the follow up of patients with Behçet's disease. Mod Rheu-matol 2009;19 (in press).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.